Is a complete BEAM research report available?

No complete published report is available for Beam Therapeutics Inc. (BEAM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Beam Therapeutics Inc. (BEAM)

NASDAQ: BEAM · USD

$26.0

-0.27 (-1.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BEAM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.6B
Revenue (ttm)	164M
Net income (ttm)	-66M
EPS (ttm)	-$0.64
Shares out	99.5M
Volume	1,577,531
Beta	2.18
Price target	$52.3	+101.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 164M
Net income (ttm): -66M
EPS (ttm): -$0.64
Market cap: 2.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BEAM indicators

Market & fundamental data

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000789073
Company name	Beam Therapeutics Inc.
Country	United States
Country code	US
Cusip	07373V105
Employees	522
Employees Change	11%
Employees Change Percent	2.15
Enterprise value	$1.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-02-06
Isin	US07373V1052
Last refreshed	2026-07-30
Market cap	$2.6B
Market cap category	Mid-Cap
Price	$26.02
Price currency	USD
Rev Per Employee	314,197.32x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2080
Symbol	BEAM
Website	https://beamtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.55%
EV Sales Forward	21.29x
EV/Sales	9.93x
FCF yield	-14.82%
P/B ratio	2.22x
P/S ratio	15.79x
PS Forward	33.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-226.58%
EBITDA Margin	-212.94%
Gross margin	-146.9%
Gross Profit	$-240.9M
Net Income	$-66M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-40.23%
Profit Margin	-40.23%
Profit Per Employee	$-126,398
ROA	-15.76
Roa5y	-15.43
ROCE	-26.43
ROE	-5.77
Roe5y	-34.74
ROIC	-17.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	24.94%
Cagr3y	-6.05%
Cagr5y	-21.74%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth	157.97x
Revenue Growth Q	324.87x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	28.83x
Revenue Growth5 Y	484.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.11
Assets	$1.5B
Cash	$1.2B
Current Assets	$1.3B
Current Liabilities	$74.6M
Debt	$250.8M
Debt Equity	$0.22
Equity	$1.2B
Liabilities	$316.4M
Long Term Assets	$213.8M
Long Term Liabilities	$241.8M
Net Cash	$960.8M
Net Cash By Market Cap	$37.1
Net Cash Growth	-9.51%
Net Debt Equity	$-0.83
Tangible Book Value	$1.2B
Tangible Book Value Per Share	$11.71
WACC	14.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	16.99
Net Working Capital	$-4.5M
Quick ratio	16.25
Working Capital	$1.2B
Working Capital Turnover	$0.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.47%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	24.92%
200-day SMA	28.1
3Y total return	-17.08%
50-day SMA	30.75
50-day SMA vs 200-day SMA	50over200
5Y total return	-70.64%
All Time High	138.5
All Time High Change	-81.22%
All Time High Date	2021-07-02
All Time Low	13
All Time Low Change	100.15%
All Time Low Date	2020-03-16
ATR	1.96
Beta	2.18
Beta1y	2.77
Beta2y	2.39
Ch YTD	-6.13
High	27.02
High52	38.26
High52 Date	2026-07-07
High52ch	-31.99%
Low	25.65
Low52	15.6
Low52 Date	2025-08-21
Low52ch	66.8%
Ma50ch	-15.39%
Premarket Change Percent	0
Premarket Price	$26.29
Premarket Volume	2,210
Price vs 200-day SMA	-7.4%
RSI	36.48
RSI Monthly	48.67
RSI Weekly	46.87
Sharpe ratio	0.61x
Sortino ratio	1.11
Total Return	-22.47%
Tr YTD	-6.13
Tr1m	-25.25%
Tr1w	-2.33%
Tr3m	-14.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	10
Analyst Price Target Top	$54
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.11
Earnings Revenue Estimate	18,923,600x
Earnings Revenue Estimate Growth	123.52x
Operating Income	$-371.6M
Operating margin	-226.6
Price target	$52.31
Price Target Change	$101
Price Target Change Top	$108

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	87,937,354%
Float Percent	88.35%
Net Borrowing	93,886,000
Shares Insiders	1.47%
Shares Institutions	96.34%
Shares Out	99,536,654
Shares Qo Q	-1.59%
Shares Yo Y	22.47%
Short Float	26.4%
Short Ratio	8.56
Short Shares	23.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-470.5M
Adjusted OCF	-456,337,000
Average Volume	2,451,454.4x
Bv Per Share	11.71
CAPEX	$-14.1M
Ch1m	-25.25
Ch1w	-2.33
Ch1y	24.92
Ch3m	-14.86
Ch3y	-17.08
Ch5y	-70.64
Ch6m	-10.34
Change	-1.03%
Change From Open	-0.65
Close	26.29
Days Gap	-0.38
Depreciation Amortization	22,371,000
Dollar Volume	41,047,356.6
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-371.6M
EBITDA	$-349.3M
EPS	$-0.64
F Score	3
FCF	$-383.8M
FCF EV Yield	-23.56x
FCF Per Share	$-3.86
Financing CF	101,278,000
Fiscal Year End	December
Founded	2,017
Investing CF	28,920,000
Ipr	53.06
Iprfo	8.42
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Ma150	29.09
Ma150ch	-10.56%
Ma20	30.21
Ma20ch	-13.87%
Net CF	-239,533,000
Next Earnings Date	2026-08-11
Open	26.19
Optionable	Yes
Position In Range	27.01
Post Close	26.02
Postmarket Change Percent	-0.12
Postmarket Price	$25.99
Ppne	199,395,000
Pre Close	26.29
Price Date	2026-07-29
Ptbv Ratio	2.22
Relative Volume	0.64x
Revenue	164,011,000x
SBC By Revenue	52.8x
Share Based Comp	86,606,000
Tr6m	-10.34%
Us State	Massachusetts
Volume	1,577,531
Z Score	2.83

Beam Therapeutics Inc. (BEAM)

Coverage state: Market snapshot only — no published research

Generate the first BEAM analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BEAM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BEAM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BEAM

Frequently asked questions